HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism.

Abstract
Accumulating evidence has shown the adverse effect of long-term hyperaldosteronism on cardiovascular morbidity that is independent of blood pressure. However, the diagnosis of primary aldosteronism (PA) remains a challenge for patients who present with subtle or atypical features or have chronic kidney disease (CKD). SPECT/CT has proven valuable in the diagnosis of a number of conditions. The aim of this study was to determine the usefulness of I-131 NP-59 SPECT/CT in patients with atypical presentations of PA and in those with CKD. The records of 15 patients with PA were retrospectively analyzed. NP-59 SPECT/CT was able to identify adrenal lesion(s) in CKD patients with suspected PA. Patients using NP-59 SPECT/CT imaging, compared with those not performing this procedure, significantly featured nearly normal serum potassium levels, normal aldosterone-renin ratio, and smaller adrenal size on CT and pathological examination and tended to feature stage 1 hypertension and non-suppressed plasma renin activity. These findings show that noninvasive NP-59 SPECT/CT is a useful tool for diagnosis in patients with subclinical or atypical features of PA and those with CKD.
AuthorsYi-Chun Chen, Yu-Chieh Su, Chang-Kuo Wei, Jainn-Shiun Chiu, Chih-En Tseng, Shao-Jer Chen, Yuh-Feng Wang
JournalJournal of biomedicine & biotechnology (J Biomed Biotechnol) Vol. 2011 Pg. 209787 ( 2011) ISSN: 1110-7251 [Electronic] United States
PMID21541242 (Publication Type: Journal Article)
Chemical References
  • Iodine Radioisotopes
  • Adosterol
Topics
  • Adosterol
  • Adult
  • Aged
  • Case-Control Studies
  • Demography
  • Female
  • Humans
  • Hyperaldosteronism (diagnostic imaging, pathology)
  • Iodine Radioisotopes
  • Male
  • Mass Screening
  • Middle Aged
  • Radionuclide Imaging
  • Reproducibility of Results
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: